The phenotypes of EDMCs are CD45+CD235a+CD71+CD11b+CD33+HLA-DR- in patients with cancer and CD45+Ter119+CD71+CD11b+Gr1+ in tumor-bearing mice. This evidence concerns the gene PTPRC and neoplasm.